RecruitingNot ApplicableNCT07507903

OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device

OBPM_PANDA2026: Pivotal Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring (OBPM) Device at Wrist Against Double Auscultation: a Multicenter Prospective Clinical Study


Sponsor

Aktiia SA

Enrollment

200 participants

Start Date

Apr 14, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study, with N = 85 participants minimum over 3 visits spread over 7 days, has been designed to assess the accuracy and precision of the Blood Pressure and pulse rate values as generated by Aktiia.product-G1-US for up to 7 days after initialization in a cohort of subjects representative of the US population.


Eligibility

Min Age: 22 YearsMax Age: 59 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Device under test evaluation against references for people with hypertension. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 59 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDevice under test evaluation against references

Blood pressure and pulse rate measurements will be taken at different timepoints with the device under test and references. Main references: Cuff for double auscultation for blood pressure and Electrocardiogram for pulse rate.


Locations(1)

Parameters Research Laboratory

Broomfield, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07507903


Related Trials